Related Experiment Videos
Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine
1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Abstract:
The retinoblastoma gene product (Rb), a nuclear phosphoprotein, functions as a tumor suppressor that is inactivated in retinoblastoma and other malignancies. The hypophosphorylated forms of Rb are observed in the G0/G1 phase of the cell cycle, whereas the hyperphosphorylated forms predominate in S and G2/M phases, suggesting that phosphorylation/dephosphorylation of Rb may regulate progression through the growth cycle. However, little is known about the intracellular signals that regulate phosphorylation/dephosphorylation of Rb. We show that D-erythro-sphingosine potently induces early dephosphorylation of Rb. Initial dephosphorylation was observed as early as 1 h after treatment of hematopoietic cells with sphingosine, whereas complete shift to the dephosphorylated form was seen 4 h after treatment. These effects occurred at concentrations of sphingosine as low as 100-500 nM, with maximal effects observed at 1-2.5 microM. These effects were specific to sphingosine, inasmuch as other lipids, amphiphiles, and long chain amino bases, as well as structural analogs of sphingosine, failed to induce dephosphorylation of Rb. Also, activation of second messenger systems including protein kinase C, cAMP-dependent kinases, and calcium ionophores, as well as inhibition of serine/threonine protein phosphatases, failed to induce dephosphorylation of Rb. Induction of Rb dephosphorylation by sphingosine preceded inhibition of growth and a specific arrest in the G0/G1 phase of the cell cycle. These studies, for the first time, identify an intracellular activator of Rb.
Insights
Sphingosine dephosphorylates the retinoblastoma gene product (Rb), a key tumor suppressor. This finding reveals sphingosine as the first identified intracellular activator of Rb, impacting cell cycle regulation.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Oncology
Background:
- The retinoblastoma gene product (Rb) is a crucial tumor suppressor protein.
- Rb phosphorylation state correlates with cell cycle phases (G0/G1 vs. S/G2/M).
- Intracellular signals regulating Rb phosphorylation remain largely unknown.
Purpose of the Study:
- To identify intracellular signals that regulate Rb phosphorylation/dephosphorylation.
- To investigate the effect of D-erythro-sphingosine on Rb phosphorylation.
- To determine if sphingosine influences cell cycle progression.
Main Methods:
- Treatment of hematopoietic cells with D-erythro-sphingosine.
- Analysis of Rb phosphorylation status via Western blot.
- Assessment of cell growth inhibition and cell cycle arrest.
- Testing specificity using various lipids, analogs, and signaling pathway modulators.
Main Results:
- Sphingosine potently induced early dephosphorylation of Rb in hematopoietic cells.
- Dephosphorylation occurred at low nanomolar to micromolar concentrations of sphingosine.
- Sphingosine-induced Rb dephosphorylation preceded growth inhibition and G0/G1 cell cycle arrest.
- Specificity was demonstrated as other lipids and signaling pathway activators did not induce Rb dephosphorylation.
Conclusions:
- D-erythro-sphingosine is the first identified intracellular activator of Rb.
- Sphingosine-mediated Rb dephosphorylation plays a role in cell cycle regulation.
- This discovery opens new avenues for understanding tumor suppression and cell growth control.